Description
Overview
The D-Retro-Inverso modified version of FOXO4 improves protease resistance and cell penetration. More stable than natural FOXO4. Research materials.
| Chemical Class | DRI modified peptide |
| Dosage Form | Lyophilized powder |
| Specification | for research |
| Storage | Refrigerate at 2-8°C |
Mechanism of Action
- FOXO4-p53 interference: same as F4, but with longer half-life
- DRI modification: D-amino acid + reverse sequence structure, resistant to protease degradation
- Relevant to indications: Enhanced senolytic candidates.
| Indication | Mechanism | Evidence |
|---|---|---|
| Senescent cell removal | FOXO4-p53 interference | animal experiments |
Dosage & Administration
- Data source: Based on ClinicalTrials.gov public trial protocol/approved instructions
Safety Information
- Data source: Based on PubMed safety research literature
Regulatory Status
Drug Interactions
- Data source: Derivation based on mechanism of action + PubMed literature
FAQ
Disclaimer: This product is intended for research purposes only. Not for human consumption or therapeutic use. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.





Reviews
There are no reviews yet.